GOLDMAN SACHS GRP INC./ US38141G1040 /
23/05/2024 08:17:54 | Chg. -4.60 | Volume | Bid21:59:26 | Ask21:59:26 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
426.65EUR | -1.07% | 0 Turnover: 0.00 |
422.90Bid Size: 20 | 423.75Ask Size: 20 | 136.65 bill.EUR | - | - |
GlobeNewswire
14:00
Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
13:45
Victory Square Company Announces Access to Tirzepatide and GLP-1 Injections to its Weight Loss Portf...
GlobeNewswire
13:00
Hydreight Technologies through its associated Medical network now offer Tirzepatide to Product Offer...
GlobeNewswire
05:53
GlobalFoundries Announces Pricing of $950 Million Secondary Offering of Ordinary Shares, Including C...
GlobeNewswire
22/05
BrightSpring Health Services, Inc. to Participate in Three Upcoming Investor Conferences
GlobeNewswire
09/05
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
11/04
C.K. McWhorter Continues Goldman Sachs Communications: Potential Strong Partnership Ties